ID
19760
Beschrijving
The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS. Documentation process: This form is to be obtained in Screening.
Trefwoorden
Versies (1)
- 27-01-17 27-01-17 -
Geüploaded op
27 januari 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Medical History CRFs Multiple Sclerosis Tysabri NCT00027300
Medical History CRFs Multiple Sclerosis Tysabri NCT00027300
- StudyEvent: ODM
Beschrijving
If 'Yes' record each detail below. If a category has multiple details, record each on a separate line. Mark if resolved or current.
Beschrijving
Line
Datatype
integer
Alias
- UMLS CUI [1]
- C0750480
Beschrijving
Category Number
Datatype
text
Alias
- UMLS CUI [1]
- C0683312
Beschrijving
resolved or current
Datatype
integer
Beschrijving
details
Datatype
text
Alias
- UMLS CUI [1]
- C1522508
Similar models
Medical History CRFs Multiple Sclerosis Tysabri NCT00027300
- StudyEvent: ODM